Mission

IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions.

Join IDEOM

To become a stakeholder with IDEOM, participation in Delphi surveys, web conferences, workgroups, and in-person meetings will be required. PLEASE APPLY HERE

Interested in creating a workgroup?
SUBMIT YOUR APPLICATION HERE

A Note From Our President:

"The true finish line is when the patient gets to the right doctor and the right treatment and their disease has minimal to no impact on their quality of life."

-Alice Gottlieb, MD, PhD

Welcome to the International Dermatology Outcome Measures

International Dermatology Outcome Measures is a non-profit organization seeking to develop and validate measures throughout dermatology with an initial focus on psoriatic disease. IDEOM strives for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Launched in 2013, IDEOM seeks to bring together physicians, researchers, government agencies, pharmaceutical companies, payers and patients from around the globe to develop and validate measures throughout the field of dermatology with an initial focus on psoriasis.

To become a stakeholder with IDEOM, participation in Delphi survey's, web conferences, workgroups, and in-person meetings will be required. PLEASE APPLY HERE

   


IN THE NEWS

IDEOM President ALICE GOTTLIEB,MD,PHD RECEIVES OUTSTANDING SCIENTIFIC ACHIEVEMENT AWARD BY THE NATIONAL PSORIASIS FOUNDATION

National Psoriasis Foundation has chosen IDEOM Founder and President Dr. Alice Gottlieb to receive the Outstanding Scientific Achievement award for 2021.

Through the NPF Researcher Awards program, NPF honors scientists who have made a unique impact on psoriatic disease research.

The Outstanding Scientific Achievement award recognizes outstanding scientific achievement in psoriatic disease research, taking into consideration independence of thought, originality, significance of discovery, and impact on his/her area of research.

CALL FOR ABSTRACTS

NEW DEADLINE: October 1, 2021

The IDEOM Board of Directors will select abstracts for poster presentation at the 2021 Virtual Annual Meeting during designated breaks.

Abstract processing fee: There is no processing fee to have your abstract considered if you are an IDOEM stakeholder.

INDUSTRY: Corporate members of IDEOM may submit the allowed amount of posters per your membership category. Please contact Amanda Pacia if you are unsure of your category (Amanda@dermoutcomes.org).

Industry representatives who are not corporate members and wish to submit shall pay a $1,000 fee per abstract.

Eligibility: Stakeholders, trainees, and Industry representatives at any level are eligible to submit an abstract. Abstracts dealing with one of the topics below can be submitted:

  • Outcomes in Psoriatic Arthritis
  • Outcomes in Psoriasis
  • Outcomes in Hidradenitis Suppurativa
  • Outcomes in Acne
  • Outcomes in Acitinic Keratosis
  • Outcomes in Alopecia Areata
  • Outcomes in Vitiligo
  • Outcomes in Itch
  • Outcomes in Cutaneous T-Cell Lymphoma
  • Outcomes in other areas of dermatology

   


A Prayer for IDEOM

Adapted from the Mishkan T'Filah,: A Reform Siddur. Central Conference of American Rabbis, New York, 2007.


UPCOMING EVENTS

2021 IDEOM
Annual Meeting
NEW DATES!

NEW DATES:
November 19 - 20, 2021

The IDEOM Annual Meeting is open to all IDEOM Stakeholders. If you are not an IDEOM Stakeholder, please contact Amanda Pacia at amanda@dermoutcomes.org to learn more.
Additional Details Coming Soon...


IDEOM POLICY:

To remain eligible for travel reimbursement for all future in-person meetings, all stakeholders MUST attend the two (2) days of the virtual annual meeting in its entirety.


HS Grants

Thank you all who have submitted an application for the IDEOM HS grant. IDEOM is seeking grant applications that encourage research into the disease hidradenitis suppurativa (HS). The goal is to stimulate the development of new research programs in the field of HS capable of competing for long-term funding from the National Institutes of Health or other agencies in the future.

AWARD WINNER WILL BE ANNOUNCED AT IDEOM 2021 ANNUAL MEETING


Why Join IDEOM?

Join a community of like-minded researchers and stakeholders as we work for the establishment of patient-centric outcomes to enhance the research and treatment of dermatological conditions. Learn the facts...